Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlencowe Resources Regulatory News (BRES)

Share Price Information for Blencowe Resources (BRES)

Share Price is delayed by 15 minutes
Get Live Data
8.10    0.06 (0.75%)
Bid:
7.90
Ask:
8.30
Spread: 0.40 (5.063%)
Market Cap: £39.85m
BRES Live PriceLast checked at - London Stock Exchange

Intraday Blencowe Resources Share Chart

Presentation & Interview

1 Dec 2025 08:58

RNS Number : 6572J
Blencowe Resources PLC
01 December 2025
 

01 December 2025

Blencowe Resources Plc

("Blencowe" or the "Company")

 

Updated Corporate Presentation & CEO DFS Interview Links

 

Blencowe Resources Plc, the natural resources company developing the Orom-Cross graphite project in Uganda, is pleased to announce that it has published an updated corporate presentation incorporating the key outcomes of the recently released Definitive Feasibility Study ("DFS").

 

The new presentation includes a summary of the DFS results, which confirmed Orom-Cross as a Tier-1 graphite project with US$1.1Bn NPV10, 96% IRR, low capex and world-class margins, as well as details of the integrated downstream USPG facility and a scalable development pathway.

It also highlights the significant further growth potential, with further JORC update expected to incorporate the additional 192 step-out drillholes not included in the DFS already scheduled for early 2026.

 

The updated presentation is available on the Company's website:

https://blencoweresourcesplc.com/presentation/

 

The Company also directs shareholders to two recent video interviews with CEO Mike Ralston, in which he discusses the DFS outcomes, the transition into P1 financing, downstream strategy, and the long-term expansion potential:

 

• Interview 1 - Vox Markets, Blencowe delivers big resource update and even bigger DFS:

https://www.youtube.com/watch?v=gzRsMm62yxA

• Interview 2 - Focus IR, Blencowe releases outstanding DFS for its world-class Orom-Cross graphite mine in Uganda:

https://www.youtube.com/watch?v=7Gkx7nDdceo

 

These materials provide further insight into the strong technical and commercial platform now established for Orom-Cross following the DFS.

 

 

**ENDS**

 

 

For further information please contact:

 

Blencowe Resources Plc

Sam Quinn

 

www.blencoweresourcesplc.com

Tel: +44 (0)1624 681 250

info@blencoweresourcesplc.com

 

Investor Relations

Sasha Sethi

Tel: +44 (0) 7891 677 441

sasha.sethi@blencoweresources.com

 

Tavira Financial 

Jonathan Evans

Tel: +44 (0)20 3192 1733

jonathan.evans@tavira.group

 

 

Twitter https://twitter.com/BlencoweRes

LinkedIn https://www.linkedin.com/company/72382491/admin/

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFSISAFEISEIE
Date   Source Headline
19th Nov 20248:00 amRNSShareholder Question & Answers
13th Nov 20247:00 amRNS6,700m Drilling Programme to Commence
12th Nov 20243:11 pmRNSHolding(s) in Company
7th Nov 20247:00 amRNSResults of Retail Offer
6th Nov 20247:01 amRNSBookBuild Retail Offer
6th Nov 20247:00 amRNSCapital Raise of £1.5m
8th Oct 20247:00 amRNSGlobal MSP Accreditation
5th Sep 20247:00 amRNSMoU signed for Graphite Beneficiation in Uganda
2nd Sep 20247:00 amRNS600 tonne Processing Graphite to Battery Ready SPG
22nd Jul 20247:00 amRNSIssue of Equity
15th Jul 20247:00 amRNSDFC Grant Fourth Tranche
5th Jul 20247:00 amRNSConversion of 600t bulk sample to concentrate
25th Jun 20247:17 amRNS600t Bulk Sample Nearing Completion
14th Jun 20247:00 amRNSHalf-year Report
10th Jun 20247:00 amRNSFirst offtake for 15,000 tonnes
3rd Jun 20247:00 amRNSCorporate Presentation Updated
28th May 20249:00 amRNSCEO Video Interview
15th Apr 20247:00 amRNSBulk Sample Update
10th Apr 20247:00 amRNSReceipt of Third Tranche from DFC
26th Feb 20248:52 amRNSResult of AGM
9th Feb 20247:00 amRNSSubscription & Conditional Subscription - Replace
6th Feb 20247:00 amRNSSubscription & Conditional Subscription
31st Jan 20247:00 amRNSAnnual Financial Report
29th Jan 20247:00 amRNSDFC LOI Regarding Project Financing
25th Jan 20247:00 amRNSReceipt of further $1m Tranche from the DFC
2nd Jan 20247:00 amRNSProject Update
11th Dec 20237:00 amRNSDFS Update
30th Oct 20237:00 amRNSSPG Test Work Completed
10th Oct 202312:16 pmRNSReceipt of $1m Grant First Tranche from DFC
22nd Sep 20237:05 amRNSCorporate Presentation
22nd Sep 20237:00 amRNSDFC Grant Completed
4th Sep 20237:00 amRNSBulk Sampling Completed
23rd Aug 20237:16 amRNSHolding(s) in Company
14th Aug 20237:57 amRNSBulk Sampling Update & China Visit
18th Jul 20237:00 amRNSWarrants Update
22nd Jun 20231:49 pmRNSCEO Interview
19th Jun 20237:00 amRNSMetallurgical test work results
2nd Jun 20237:00 amRNSHalf-year Report
24th May 20238:59 amRNSHolding(s) in Company
18th May 20237:46 amRNSPlacing to Raise £635,000
9th May 20237:00 amRNSWebinar Today
2nd May 20237:11 amRNSInvestor Webinar & Updated Presentation
27th Apr 20233:22 pmRNSStrategic Funding Partner for Orom-Cross
18th Apr 20237:00 amRNSWarrant Expiry Extension
2nd Mar 20237:49 amRNSResearch Note
27th Feb 20237:00 amRNSBulk Sampling Complete
15th Feb 202310:17 amRNSResult of AGM
23rd Jan 20237:00 amRNSAppointment of Leading Engineering Firm to DFS
16th Jan 20237:00 amRNSFinal Metallurgical Testing Programs
13th Jan 20237:00 amRNSAnnual Results 30 September 2022 & Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.